New Analysis by HDA Finds Importation Proposals Are Too Expensive and Pose Health Risks to Patients

July 16, 2019

A report just released the HDA Research Foundation demonstrates that federal importation proposals to allow drug importation are devoid of practical implementation guidance and funding, so will fail to guarantee federal safety and quality standards for prescription medication.

Read More

Counterfeit Adderall Dealers Arrested After Being Traced to their Stamps.com Account

July 15, 2019

A pair of fake Adderall dealers who sold their counterfeits on the web has been arrested as a result of their Stamps.com account, Quartz reports. The duo allegedly sold almost $9 million worth of counterfeit Adderall by the time Tzu Yang “Issac” Lin and Meng Ting “Leo” Hu were arrested.

Read More

Lincoln, Nebraska Man Convicted, “Fentanyl Pills” Entered in Evidence

July 13, 2019

The U. S. Department of Justice (DOJ) is reporting that Sabas Rodriguez-Cisneros has been convicted of conspiracy to distribute methamphetamine and other charges in a drug conspiracy that started in October 2016. According to the DOJ, U.S. Customs and Border Patrol intercepted a package for Rodriguez-Cisneros that was being shipped to his girlfriend contained 400…

Read More

Counterfeit Pill Drug Ring In San Antonio Sold Over 800,000 Fake Pills In Two Years

July 12, 2019

Recent news out of Texas gave updates on the cases against three men who were part of a major counterfeit pill ring busted in San Antonio in 2017. The ringleader entered a guilty plea and faces up to 30 years in prison, a supplier received a 21-year sentence, and a distributor waits to see what his future holds…

Read More

New Jersey Legislature Works to Increase Penalties for Drug Counterfeiters

July 11, 2019

In June, the New Jersey Assembly passed A-5037, a bill that increases penalties for those who create, distribute or administer counterfeit, adulterated or misbranded medical drugs and devices. The legislation, which has been sent to the New Jersey Senate’s Budget and Appropriations Committee, would make the sale of more than 100 units of fake medicine punishable by a sentence of five to ten years, a fine of up to $150,000, or both.

Read More

Drug Distribution Experts Warn That State Plans To Import Foreign Drugs Will Undermine Safety

July 11, 2019

This editorial by Adam Fein and Dirk Rodgers was published in Stat News on July 11, 2019. In it, Fein and Rodgers warn that plans by states to create drug importation programs will open new pathways for counterfeit drugs to enter the U.S. drug supply chain…

Read More

June Was a Dangerous Month in Arizona as Over 130,000 Fake Pills Made with Fentanyl Seized Throughout State

July 10, 2019

A series of eight different busts in Arizona this month has yielded approximately 132,000 counterfeit pills made with fentanyl, with seizures happening all across the Grand Canyon state.

Read More

Importation Is An Opportunity For Organized Crime to Expand Counterfeit Drug Profits, DEA Veteran Says

June 28, 2019

This editorial by retired DEA agent Douglas Hebert was published in The Arizona Capital Times ,on June 27, 2019. In it, Hebert explains how drug importation programs will help organized crime expand their $200 billion-a-year counterfeit pharmaceutical industry into the U.S., at the expense of Americans.

Read More

National Pharmacy Organizations Ask HHS Secretary Azar for Clarity on Drug Importation Proposals

June 28, 2019

On June 24, 2019, the National Alliance of State Pharmacy Associations (NASPA), along with the American Pharmacists Association (APhA), and the National Association of Chain Drug Stores (NACDS) wrote a joint letter to U.S. Health and Human Services (HSS) Secretary Alex Azar questioning the wisdom of poorly thought-out importation proposals.

Read More

“Canada cannot act as a drugstore for the United States,” says academic

June 19, 2019

In this editorial, which was published by the Fraser Institute on June 13, 2019, economist Dr. Kristina Acri argues against importation, concluding: “Diverting drugs meant for Canadian patients to the U.S. through state importation schemes will create shortages for Canadian patients and increase pressure on potentially unscrupulous suppliers to source drugs from wherever they can, opening the door to counterfeiters.”

Read More